Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02498860
What this trial is testing

Efficacy and Safety of Adjuvant Pemetrexed Plus Cisplatin for Adenocarcinoma of Lung

Who this might be right for
AdenocarcinomaLung Neoplasm
Chonnam National University Hospital 106
Not applicableStudy completedNCT01037023
What this trial is testing

Regulatory Hycamtin(Oral) PMS

Who this might be right for
Lung Cancer, Small Cell
GlaxoSmithKline 92
Testing effectiveness (Phase 2)Active Not RecruitingNCT05015010
What this trial is testing

Alectinib in Neo-adjuvant Treatment of Stage III NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Gruppo Oncologico Italiano di Ricerca Clinica 33
Early research (Phase 1)Looking for participantsNCT07164313
What this trial is testing

ZW251 in Participants With Advanced Solid Tumors

Who this might be right for
Hepatocellular CarcinomaSquamous Cell Non-Small Cell Lung CancerGerm Cell Tumor
Zymeworks BC Inc. 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT06704620
What this trial is testing

Study of Tislelizumab and Platinum-based Chemotherapy Combination With H1 Receptor Antagonist（Diphenhydramine）in Advanced and Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Advanced and Metastatic NSCLC
Tianjin Medical University Cancer Institute and Hospital 430
Testing effectiveness (Phase 2)Ended earlyNCT00280748
What this trial is testing

Whole-Brain Radiation Therapy and Pemetrexed in Treating Patients With Brain Metastases From Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerMetastatic Cancer
UNC Lineberger Comprehensive Cancer Center 10
Large-scale testing (Phase 3)Active Not RecruitingNCT06500455
What this trial is testing

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Digestive System Carcinoma+7 more
NRG Oncology 274
Early research (Phase 1)UnknownNCT04432857
What this trial is testing

AN0025 and Pembrolizumab Combination in Advanced Solid Tumors

Who this might be right for
Triple-negative Breast CancerNSCLC, Squamous or Non-SquamousUrothelial Carcinoma of the Bladder+2 more
Adlai Nortye Biopharma Co., Ltd. 63
Testing effectiveness (Phase 2)Study completedNCT02414139
What this trial is testing

Study of Oral cMET Inhibitor INC280 in Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Novartis Pharmaceuticals 373
Testing effectiveness (Phase 2)Looking for participantsNCT05692635
What this trial is testing

Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance

Who this might be right for
Brain MetastasesNonsmall Cell Lung Cancer Stage III
Wake Forest University Health Sciences 60
Testing effectiveness (Phase 2)Ended earlyNCT00554775
What this trial is testing

WBRT & Erlotinib in Advanced NSCLC and Brain Metastases

Who this might be right for
Lung CancerMetastatic Cancer
University College, London 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06483672
What this trial is testing

Furmonertinib Combined With Anlotinib in Lung Adenocarcinoma Patients With EGFR Mutations and Brain Metastases

Who this might be right for
Adenocarcinoma of Lung Metastatic to Brain
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 27
Post-approval studies (Phase 4)UnknownNCT03799601
What this trial is testing

Docetaxel Combined With Carboplatin Plus Anlotinib as First Line Treatment in NSCLC

Who this might be right for
NSCLC
Tongji Hospital 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06779539
What this trial is testing

Neoadjuvant Ensartinib in ALK Positive Resectable Stage II to III Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
West China Hospital 33
Post-approval studies (Phase 4)UnknownNCT04356222
What this trial is testing

Efficacy and Safety of Durvalumab in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis

Who this might be right for
Leptomeningeal MetastasisDurvalumab
Hui Bu 30
Not applicableStudy completedNCT05491239
What this trial is testing

Optimal Postoperative Pain Management After Lung Surgery (OPtriAL)

Who this might be right for
Lung CancerPain, PostoperativeVATS+2 more
Maxima Medical Center 450
Post-approval studies (Phase 4)Looking for participantsNCT03340506
What this trial is testing

Dabrafenib and/or Trametinib Rollover Study

Who this might be right for
MelanomaNon Small Cell Lung CancerSolid Tumor+2 more
Novartis Pharmaceuticals 100
Not applicableEnrolling By InvitationNCT06041906
What this trial is testing

International Registry of Congenital Portosystemic Shunt (IRCPSS)

Who this might be right for
Congenital Portosystemic ShuntCPSS (Congenital Portosystemic Shunt)
Prof. Valérie Mc Lin 500
Testing effectiveness (Phase 2)UnknownNCT02066038
What this trial is testing

Intermittent and Maintenance of Erlotinib in Combination With Pemetrexed/Carboplatin in Ⅲb/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation

Who this might be right for
Lung, Carcinoma
Sun Yat-sen University 60
Testing effectiveness (Phase 2)Ended earlyNCT03367819
What this trial is testing

Isatuximab in Combination With REGN2810 (Cemiplimab) in Patients With Advanced Malignancies

Who this might be right for
Prostate CancerNon-small Cell Lung Cancer
Sanofi 44
Next Page